Area of research
Pathology and Forensic Medicine · Genetics
Research interest
Research interests include Medicine, Rituximab, Follicular lymphoma, Internal medicine, Hazard ratio, and International Prognostic Index.
Patient-Reported Outcomes in Patients With <i>PIK3CA</i>-Mutated Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer From SOLAR-1
Second‐line and subsequent therapy and outcomes for follicular lymphoma in the United States: data from the observational National LymphoCare Study
Outcomes following watchful waiting for stage <scp>II</scp>–<scp>IV</scp> follicular lymphoma patients in the modern era
Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices